Clinical trial
CARISMA: Cardiac Arrhythmias and Risk Stratification After MyoCardial…
NCT00145119 · Medtronic Cardiac Rhythm and Heart Failure, Industry · Completed
Key facts
| NCT number | NCT00145119 |
|---|---|
| Title | CARISMA : Cardiac Arrhythmias and Risk Stratification After MyoCardial Infarction |
| Official title | Incidence and Prediction of Life-threatening Cardiac Arrhythmias in Patients With Depressed Left Ventricular Function After Acute Myocardial Infarction |
| Lead sponsor | Medtronic Cardiac Rhythm and Heart Failure, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Acute Myocardial Infarction |
| Enrollment | 312 |
| Start date | Aug 1, 2001 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Sep 5, 2005 |
| Last update posted | Jul 2, 2025 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: